Search

Author/Creator Polis, Adam

3. Safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine, V116, in healthy adults: phase 1/2, randomised, double-blind, active comparator-controlled, multicentre, US-based trial. Issue 2 (February 2023)

Authors:
Platt, Heather; Omole, Tosin; Cardona, Jose; Fraser, Neil J; Mularski, Richard A; Andrews, Charles; Daboul, Nizar; Gallagher, Nancy; Sapre, Aditi; Li, Jianing; Polis, Adam; Fernsler, Doreen; Tamms, Gretchen; Xu, Weifeng; Murphy, Rocio; Skinner, Julie; Joyce, Joseph; Musey, Luwy
Journal:
Lancet infectious diseases
Issue:
Volume 23:Issue 2(2023)
Page Start:
233
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. P08 A Phase 1, randomized, double-blind study to evaluate the safety, tolerability, and immunogenicity of a 21-valent pneumococcal conjugate vaccine (PCV) (V116) in adults. (19th January 2023)

Authors:
Platt, Heather; Fernsler, Doreen; Gallagher, Nancy; Sapre, Aditi; Polis, Adam; Hall, Lori; Tamms, Gretchen; Schwartz, Howard; Skinner, Julie; Joyce, Joseph; Murphy, Rocio; Musey, Luwy
Journal:
JAC-antimicrobial resistance
Issue:
Volume 5(2023)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗